Creatinine is synthesized in the human body at the time of muscle contractions. The glomeruli of the kidney removes creatinine from the blood and secretes it into the urine. Creatinine test is a sensitive test employed for measuring the glomerular filtration rate of the kidney. Hence, the creatinine test is extensively used to assess kidney functioning. Presently, direct and automation-ready procedures are gaining popularity in the field of research and drug discovery for measuring creatinine concentration in biological samples. Hence, demand for measuring creatinine for diagnosing kidney diseases is increasing globally. Creatinine assay kits are designed to measure creatinine in biological samples without the need for any pretreatment. Major advances in the determination of creatinine levels contribute to the diagnosis of early-stage kidney diseases. Rise in demand for the detection of mycobacteria in the urine and increase in geriatric population suffering from kidney malfunctions are key factors that are projected to boost the demand for creatinine assays in the near future. However, new developments in analytical methods and urology diagnostic techniques are paving the way for early diagnosis and treatment of kidney diseases.
The serum creatinine test is routinely performed as a part of clinical chemistry across the globe. Expansion of the creatinine measurement market can be attributed to the rising incidence and prevalence of diabetes and kidney diseases, increase in research activities in the field of diagnostic research and surge in geriatric population. Rise in government initiative to raise awareness about renal disorders and their early diagnosis is anticipated to boost the global creatinine measurement market during the forecast period. Additionally, technological advancements and favorable reimbursements are expected to fuel the market during the forecasting period.
The creatinine measurement market can be segmented based on type, type of sample, product type, end-user, and region. In terms of type, the market can be bifurcated into enzymatic method and kinetic method. Based on type of sample, the market can be divided into urine and blood serum. In terms of product type, the market can be segregated into reagents and kits. Based on end-user, the creatinine measurement market can be categorized into hospital, diagnostic laboratories, and others.
In terms region, the global creatinine measurement market can be classified into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America and Europe are expected to account for large share of the market due to high awareness and adoption of testing in these regions. Asia Pacific is anticipated to be a lucrative region for the market. The market in the region is anticipated to expand at a considerable pace during the forecast period due to the rise in adoption of advanced diagnostic testing and expansion of health care infrastructure in countries such as India and China. Brazil is projected to account for a dominant share of the creatinine measurement market in Latin America during the forecast period.
The global creatinine measurement market is fragmented with the presence of many global and regional players operating across all regions. Key players operating in the global creatinine measurement market include Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers, Pointe Scientific, Inc., Randox Laboratories, Ortho Clnical Diagnostics, and Diazyme Laboratories, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.